Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Steven D. Pearson
ResearcherPublications, citations & collaboration network
Steven D. Pearson is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 240 works, 8,343 citations, an h-index of 47 and an i10-index of 141.
240
Works
8,343
Citations
47
h-index
141
i10-index
IDs:OpenAlex
How has Steven D. Pearson's publication output changed over time?
ScholarIQpublication output · 1995–2023
Output declined50% over the shown period — from 2 works in 1995 to 1 in 2023.
2
1
2
1
1
2
1
1
19952000200120052006201020162023
What are the most-cited papers on Steven D. Pearson?
ScholarIQmost cited works
Patients’ trust in physicians: Many theories, few measures, and little data
Steven D. Pearson, Lisa H. Raeke
Journal of General Internal Medicine. 2000709 CitationsOPEN ACCESS
Critical Pathways as a Strategy for Improving Care: Problems and Potential
Steven D. Pearson, Dorothy Goulart-Fisher, Thomas H. Lee
Annals of Internal Medicine. 1995506 Citations
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
Dhruv S. Kazi, Andrew E. Moran, Pamela G. Coxson, Joanne Penko, Daniel A. Ollendorf, Steven D. Pearson, Jeffrey A. Tice, David Guzman, Kirsten Bibbins‐Domingo
JAMA. 2016384 CitationsOPEN ACCESS
Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer
Julia H. Hayes, Daniel A. Ollendorf, Steven D. Pearson, Michael J. Barry, Philip W. Kantoff, Susan T. Stewart, Vibha Bhatnagar, Christopher J. Sweeney, James E. Stahl, Pamela M. McMahon
JAMA. 2010257 CitationsOPEN ACCESS
Coverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’
Sean Tunis, Steven D. Pearson
S4210185023. 2006211 Citations
Related on ScholarIQ
Patients’ trust in physicians: Many theories, few measures, and little data
Paper
Critical Pathways as a Strategy for Improving Care: Problems and Potential
Paper
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
Paper
Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer
Paper
Coverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’
Paper
Cost-effectiveness of Systematic Depression Treatment for High Utilizers of General Medical Care
Paper